Ultragenyx Pharmaceutical
RARE
#3663
Rank
A$5.28 B
Marketcap
A$54.77
Share price
-0.44%
Change (1 day)
-25.38%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) Fails to deliver data

Key failure to deliver metrics for Ultragenyx Pharmaceutical:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Ultragenyx Pharmaceutical (RARE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Ultragenyx Pharmaceutical (RARE) - since 2014

Volume in USD (price x number of shares), data since 2014

Ultragenyx Pharmaceutical (RARE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$6.96 M-6.89%
2024A$7.48 M-48.37%
2023A$14.48 M344.12%
2022A$3.26 M-64.77%
2021A$9.26 M-20.49%
2020A$11.64 M-3.02%
2019A$12.01 M-75.7%
2018A$49.42 M-12.01%
2017A$56.16 M-14.47%
2016A$65.66 M-56.5%
2015A$0.15 B326.02%
2014A$35.43 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
BioMarin Pharmaceutical
BMRN
A$2.8 MA$17.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$7.34 MA$13.62 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$3.3 MA$9.95 M๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$0.58 MA$12.15 M๐Ÿ‡บ๐Ÿ‡ธ USA